Match Document Document Title
US20100204137 THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES  
Methods for the prevention and treatment of ocular disorders, in particular glaucoma, through blocking the toxic effects of β-amyloid (Aβ) derivatives, and pharmaceutical compositions for...
US20100166694 DIAGNOSTIC MARKERS OF WOUND INFECTION  
The present invention relates to a method of determining the microbial bioburden in a wound (in particular a diabetic ulcer) in a test subject, the method comprising the step of measuring the...
US20140141137 Encapsulated Antimicrobial Material  
The present invention provides an antimicrobial material in an encapsulated form, comprising (i) a core comprising an antimicrobial material and (ii) a shell of encapsulating material, wherein the...
US20070082841 Ocular administration of immunosuppressive agents  
Methods and systems for preventing or treating various ocular conditions are disclosed and described. In one aspect, for example, a method for minimizing systemic exposure to a steroid-sparing...
US20080299040 SOMATOSTATIN RECEPTOR 2 ANTAGONISTS  
The invention is directed to somatostatin analogs which are receptor antagonists of the somatostatin receptor, including receptor-selective antagonists, especially sst2-selective antagonists....
US20100035816 MEDICAMENT COMPRISING A PEPTIDE EXTRACT OF AVOCADO, WHICH IS INTENDED FOR THE TREATMENT AND PREVENTION OF ILLNESSES THAT ARE LINKED TO AN IMMUNE SYSTEM DEFICIENCY OR OXIDATIVE STRESS OR SKIN AGEING OR DRY SKIN  
The invention relates to a medicament which comprises a peptide extract of avocado and which can also comprise a composition containing D-mannoheptulose an/or perseitol, such as a water-soluble...
US20150257382 ORGANIC ACID ANTIMICROBIAL COMPOSITIONS  
An antimicrobial composition comprises at least one or more organic acid or salt in water, one or more antimicrobial agent which has limited water-solubility. The composition contains high active...
US20120238491 IMMUNOLOGICALLY ACTIVE LIPOPEPTIDES AND METHODS FOR USE THEREOF  
The present invention relates to the isolation and structure elucidation of 1-peptidyl-2-arachidonoyl-3-stearoyl glyceride (pDAG) as an active chemical entity in the caprine serum fraction, and...
US20060252681 Pain relief agents  
The present invention concerns the use of a heat shock polypeptide and/or an encoding nucleic acid sequence in the manufacture of a medicament for use in the relief of pain. In particular the...
US20060067997 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations  
Pharmaceutical formulations constituted by a lexitropsin phospholipidic complex in the form of liposomes, micelles or nanoparticles exhibit optimal pharmacological properties in respect to other...
US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae  
The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also...
US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae  
The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also...
US20080038320 COMPOSITIONS AND METHODS FOR ENHANCING VASODILATION  
Compositions and methods to achieve vasodilation through nitric oxide production pathways and Angiotensin II inhibition pathways using bovine lactoferrin and whey derived angiotensin converting...
US20050163825 Lactoferrin-treated filament materials  
Disclosed is a filament composition having a surface for reducing microbial contamination having a surface for reducing microbial contamination comprising a filament material, such as a dental...
US20080274127 AMINO ACID SUPPLEMENTATION FOR A HEALTHY MICROBIOTA ECOSYSTEM  
The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an...
US20100112038 METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS  
The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
US20070207116 Antioxidant compositions for the eye  
Ophthalmic compositions comprising at least one antioxidant agent chosen from a carotenoid, glutathione, reduced glutathione, glutathione enhancers, a lipoic acid, a flavonoid, an oleanoic acid,...
US20110311647 BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF  
The present invention provides novel compositions comprising: (a) protamine sulfate and (b) benzalkonium chloride or a silver containing particle; or (a) sodium metaperiodate and (b)...
US20080318869 Method to Promote Wound Healing  
Wound healing is impaired in irradiated animals. Substance P and its active analogs promote wound healing in irradiated animals. Substance P and its analogs can be used to treat animals irradiated...
US20150045289 METHOD OF PRE-PREPARING MEDICATIONS FOR THERAPEUTIC USES  
The present invention relates to the method of pre-preparing pharmaceutical compositions for therapeutic uses, particularly pre-preparing medications for treating patients (e.g., cancer patients...
US20060216302 Immunological markers  
Compounds, compositions and methods for identifying human or other animals having a particular characteristic, by administration of an antigenic marker that elicits a unique antigenic response....
US20120183585 GEL BASED WOUND DRESSING AND A METHOD OF SYNTHESIZING THE SAME  
The various embodiments herein provide a gel based wound dressing comprising a lyophilized powder and a water-based solvent. The lyophilized powder comprises several nanoparticles and water...
US20100143327 Injection of fibrin sealant including an anesthetic in spinal applications  
A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus. The method includes injecting a fibrin sealant into the disc to reduce at least a...
US20120172289 MULTIFUNCTIONAL GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES FOR FLUORESCENT IMAGING AND PHOTOACTIVE ANTIMICROBIAL THERAPY  
The present invention relates to a compound of formula (I) and compositions thereof, methods of their production as well as methods for treating bacterial infection.
US20100215716 COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS  
An orthopedic implant suitable for insertion into the body of a subject, the implant comprising: a metal substrate having one or more surfaces operable to contact a bone tissue or soft tissue when...
US20130210708 METHODS OF INHIBITING AND TREATING BACTERIAL BIOFILMS BY METAL CHELATORS  
The invention presented herein provides methods and compositions for the prevention and treatment of bacterial infections. The methods are based on the discovery that depletion of bioavailable...
US20120142583 Methods of inhibiting and treating bacterial biofilms by metal chelators  
The invention presented herein provides methods and compositions for the prevention and treatment of bacterial infections. The methods are based on the discovery that depletion of bioavailable...
US20100062974 COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS  
The invention features a method for treating a subject diagnosed with, or at risk of developing, a bacterial infection by administering to the subject a combination of biologically active agents.
US20110257079 Parenteral Combination Therapy for Infective Conditions With Drug Resistant Bacterium  
The invention describes a pharmaceutical composition to combat multiple-drug-resistant bacteria in non-ocular infective conditions. Compositions comprising glycopeptides, in particular vancomycin,...
US20150224225 ANTIMICROBIAL COATING COMPOSITIONS  
The invention relates to an antimicrobial coating composition for coating articles comprising: an antimicrobial peptide and a nanoparticle bound to said antimicrobial peptide, wherein the...
US20100144598 Natural Polypeptides For Oral Health Care  
The present invention relates generally to dental diseases, caries and periodontal disease. More specifically, the invention relates to Lactoferrin and Statherin fusion proteins (STAT-LF) along...
US20100209502 Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity  
Methods and compounds for treating obesity and inducing weight loss use a functional, glycosylated leptin transport factor (LTF) polypeptide, referred to as fn/glyLTF. An unstable defective...
US20120269859 MULTIMER OF EXTRACELLULAR DOMAIN OF CELL SURFACE FUNCTIONAL MOLECULE  
As a substance which pharmacologically regulates the function of a cell surface functional molecule, a substance which has specificity and an activity or efficacy equal or superior to an antibody...
US20060263331 Therapeutic use of tumor necrosis factor-alpha mutein  
Improved methods for treating neoplastic diseases such as cancer are provided by using muteins of human tumor necrosis factor-alpha (TNF-α). Compared to wild-type human TNF-α these therapeutic TNF...
US20130209537 CONTROLLED-RELEASE ANTIBIOTIC NANOPARTICLES FOR IMPLANTS AND BONE GRAFTS  
The present invention relates to the preparation and use of antibiotic-containing nanoparticles for coating an implant including cranial implants and bone graft sites to provide for the extended...
US20090004195 SOMATOSTATIN RECEPTOR ANTAGONISTS AND GLUCOSE CONTROL OR HYPOGLYCEMIA  
The present disclosure provides methods and uses for controlling tight blood glucose levels in a subject comprising administering an effective amount of a somatostatin inhibitor. The present...
US20100285097 VAGINAL DELIVERY SYSTEM  
The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a...
US20120172288 USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO DISEASES AND CONDITIONS  
The present disclosure relates to the use of nutritional compositions including lactoferrin produced by a non-human source in supporting resistance to diseases or conditions caused by bacterial...
US20100173837 DOSING FORMS AND REGIMENS COMPRISING 3-[(R)-2-(N,N-DIMETHYLAMINO)ETHYLTHIO-SAR]-4-(GAMMAHYDROXYMETHYLLEUCINE)CYCLOSPORINE  
Provided herein are specific doses of, and dosing regimens for, using SCY-635 in treating or preventing diseases, in particular hepatitis C virus (HCV) infection.
US20110045073 METHODS AND COMPOSITIONS OF SPHINGOLIPID FOR PREVENTING AND TREATING MICROBIAL INFECTIONS  
The present invention relates to controlled release composition for preventing and/or treating microbial infections in the oral cavity of a subject, said composition comprising a controlled...
US20080081064 Implantable Medical Device with Apertures for Delivery of Bioactive Agents  
An implantable medical device for the release of bioactive agents at desired rates is described. The device includes a body member with two or more aperture sets and an inner space. The bioactive...
US20110038866 IMPROVED FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF  
The invention provides fibronectin type III (Fn3)-based binding molecules that bind to a specific target antigen. The invention further provides bispecific Fn3-based binding molecules that bind to...
US20150005227 METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS  
Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
US20060204549 Method of improving nutrient utilisation by a mammal and a composition for use therein  
The invention relates to a method of stimulating nutrient utilization, especially through improved gastric emptying, comprising oral administration of a nutritional composition. The invention is...
US20050070460 Infection prophylaxis using immune response modifier compounds  
The present invention provides methods of providing prophylaxis to a subject against an infectious agent. In general, the methods include topically administering to the respiratory tract of a...
US20060269535 Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy  
Formulations are provided for the trigger and release of bioenergy. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex...
US20140328896 COMPOSITIONS AND METHODS FOR MODIFYING GASTROINTESTINAL FLORA  
Provided are methods and compositions for enhancing the gastrointestinal health of an animal in need thereof by administering a gastrointestinal health maintaining or improving amount of a...
US20090074751 GROWTH FACTOR FRACTION COMPOSITIONS AND METHODS  
Compositions and formulations are provided comprising a growth factor fraction and at least one glucan. Also provided are methods for making the compositions and formulations. Methods of promoting...
US20060229237 Treatment of gastrointestinal distress  
A composition and method for treating and/or preventing acute and chronic gastrointestinal distress including nausea, vomiting, lactose intolerance, obstructive symptoms, diarrhea, mucositis,...
US20140127320 DELIVERY OF BIOLOGICALLY-ACTIVE AGENTS USING VOLATILE, HYDROPHOBIC SOLVENTS  
A composition and method adapted for delivery of hydrophilic, biologically-active agents are disclosed. The composition can include a reverse microemulsion formed from at least one hydrophilic,...